Monocytes from sickle cell disease patients produce increased IL-6 compared to healthy controls after stimulation, aligning with the condition's immune profile.
Peripheral blood mononuclear cells were stimulated with TLR agonists to assess changes in cytokine production in monocytes associated with sickle cell disease.
The findings point to the potential for monocyte dysfunction contributing to infection vulnerability in sickle cell disease patients.